Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2023-02-28 00:00:00 ET · period of report 2023-02-24 · accession 0001209191-23-013685 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-02-28 | 2023-02-24 | VRTX | ALTSHULER DAVID | EVP, CSO, Gbl Research | F - Tax | $289.12 | -3,970 | 36.3K | -10% | -$1.15M | |
| M | 2023-02-28 | 2023-02-27 | VRTX | ALTSHULER DAVID | EVP, CSO, Gbl Research | S - Sale | $287.51 | -4,238 | 32.0K | -12% | -$1.22M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-24 | F | D | 3,970 | $289.12 | 36,276 | D | — | — | |
| 2 | Common | Common Stock | 2023-02-27 | S | D | 3,636 | $287.23 | 32,640 | D | — | — | (F2) Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F3) Open market sales reported on this line occurred at a weighted average price of $287.23 (range $286.80 to $287.72). |
| 3 | Common | Common Stock | 2023-02-27 | S | D | 300 | $288.74 | 32,340 | D | — | — | (F2) Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. (F4) Open market sales reported on this line occurred at a weighted average price of $288.74 (range $288.42 to $289.37). |
| 4 | Common | Common Stock | 2023-02-27 | S | D | 302 | $289.60 | 32,038 | D | — | — | (F5) Open market sales reported on this line occurred at a weighted average price of $289.60 (range $289.49 to $289.65). (F2) Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |